Future #1
A vendor-listed photoperiod strain with sparse public documentation and unverified Gorilla Glue lineage claims.
Future #1 shows up in European seed catalogs as an indica-dominant hybrid, often described as a Gorilla Glue #4 backcross or relative. The honest truth: there is no peer-reviewed chemistry, no formal genetic verification, and no clinical data on this strain. Almost everything written about it traces back to seed vendor copy. Treat THC numbers, terpene profiles, and effect claims as marketing — useful for orientation, not as proven facts. Grow it if you like the genetics story, not because anyone has verified it.
Overview
Future #1 is a photoperiod cannabis cultivar sold primarily through European seed banks, including Weedseedsexpress, where it is marketed as an indica-dominant hybrid with high THC and a resinous, sticky flower structure [1]. Outside of vendor product pages and reseller blogs, there is essentially no independent documentation of the strain — no peer-reviewed chemical analyses, no entries in major academic strain genetics databases, and no regulatory cannabinoid testing records that we have been able to locate. No data
That does not mean the strain doesn't exist or isn't worth growing. It does mean that nearly every specific claim about Future #1 — its THC content, terpene profile, effects, and parentage — originates from the people selling the seeds. Readers should weigh that accordingly.
Chemistry
Vendor listings give Future #1 a THC content in the low-to-mid 20s percent and a CBD content under 1% [1]. We have not found independent lab certificates of analysis (COAs) to confirm these numbers. No data
No dominant terpene is consistently named across vendor sources. Some descriptions mention earthy, pine, and diesel notes consistent with a Gorilla Glue–adjacent profile (which would suggest caryophyllene, myrcene, and limonene dominance), but again, no GC-MS terpene panel for this specific cultivar is publicly available. No data
More broadly, cannabinoid and terpene content within a single named strain varies widely between phenotypes, grows, and labs — even for well-studied cultivars [2][3]. A single percentage number for any strain is best read as a marketing estimate, not a specification.
Reported effects
Vendor and reseller descriptions of Future #1 emphasize a heavy, relaxing, body-forward experience typical of indica-leaning marketing copy [1]. Anecdote
There are no clinical trials, observational studies, or controlled human research on Future #1 specifically. There are no published studies on Future #1 at all that we can locate. Any claims about it helping with sleep, pain, stress, or appetite are extrapolated from general cannabis pharmacology, not from research on this strain.
It's also worth noting that the long-standing 'indica = sedating, sativa = energizing' framework is not supported by chemistry. A 2015 analysis in PLOS ONE found that indica/sativa labels poorly predict cannabinoid and terpene content [4], and chemovar-based classifications are now considered more useful than the indica/sativa binary [5]. Strong evidence So 'indica-dominant hybrid' on a Future #1 label tells you something about expected morphology and vendor positioning — not reliably about how it will feel.
Lineage
Some vendor descriptions associate Future #1 with the Gorilla Glue / GG4 lineage, or describe it as a sister or backcross selection in that family [1]. We have not found a breeder statement with verifiable provenance — for example, a documented seed-bank release note, a breeder interview, or any cross record that confirms specific parents. Disputed
This is common in modern cannabis: most strain pedigrees on the market are unverifiable claims, and genetic studies have repeatedly shown that strain names are not reliable indicators of actual genetic relationships [6]. Strong evidence Until a breeder publishes a sourced lineage or someone runs a genetic comparison, Future #1's parentage should be treated as unconfirmed.
Cultivation basics
Per vendor information, Future #1 is a photoperiod strain with a flowering window around 8-9 weeks indoors and a reported indoor yield in the ~450-550 g/m² range under good conditions [1]. It's described as forgiving for beginners and responsive to standard indica-style training (topping, LST, SCROG).
General cultivation guidance for any indica-leaning photoperiod hybrid applies:
- Vegetative photoperiod of 18/6, switching to 12/12 to trigger flowering.
- Moderate to high light intensity; modern LEDs in the 600-900 µmol/m²/s PPFD range during flower are typical for high-yield indoor grows [7].
- Watch for dense, resinous buds that can trap moisture late in flower — airflow and humidity control reduce botrytis risk.
Because there's no independent grower documentation specific to Future #1, expect to dial it in yourself rather than rely on a 'recipe.'
Marketing vs. reality
Here's the candid summary:
- What's real: Future #1 is a strain you can buy seeds of from at least one established European seed bank, with reasonably typical photoperiod hybrid characteristics on paper [1].
- What's marketing: The specific THC percentage, the implied Gorilla Glue lineage, the predicted effects, and the 'easy to grow' framing are vendor claims, not independently verified facts. Weak / limited
- What's folklore: Any suggestion that being 'indica-dominant' tells you how Future #1 will feel relies on a category that doesn't hold up to chemical analysis [4][5]. Strong evidence
If you grow Future #1, you'll learn more from your own phenotype hunt and (ideally) a lab test of the dried flower than from any product description — including this one.
Sources
- Reported Weedseedsexpress. Future #1 strain product listing (vendor catalog).
- Peer-reviewed Jikomes N, Zoorob M. The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products. Scientific Reports. 2018;8:4519.
- Peer-reviewed Smith CJ, Vergara D, Keegan B, Jikomes N. The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE. 2022;17(5):e0267498.
- Peer-reviewed Elzinga S, Fischedick J, Podkolinski R, Raber JC. Cannabinoids and Terpenes as Chemotaxonomic Markers in Cannabis. Natural Products Chemistry & Research. 2015;3:181.
- Peer-reviewed Hazekamp A, Tejkalová K, Papadimitriou S. Cannabis: From Cultivar to Chemovar II—A Metabolomics Approach to Cannabis Classification. Cannabis and Cannabinoid Research. 2016;1(1):202-215.
- Peer-reviewed Sawler J, Stout JM, Gardner KM, et al. The Genetic Structure of Marijuana and Hemp. PLOS ONE. 2015;10(8):e0133292.
- Peer-reviewed Chandra S, Lata H, Khan IA, ElSohly MA. Photosynthetic response of Cannabis sativa L. to variations in photosynthetic photon flux densities, temperature and CO2 conditions. Physiology and Molecular Biology of Plants. 2008;14(4):299-306.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Gorilla Glue #4 (GG4) — The sticky, high-THC hybrid that won the 2014 Cannabis Cups, sparked a trademark lawsuit,...